These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21323417)

  • 21. Prevalence of the CTNNB1 mutation genotype in surgically resected fibromatosis of the breast.
    Kim T; Jung EA; Song JY; Roh JH; Choi JS; Kwon JE; Kang SY; Cho EY; Shin JH; Nam SJ; Yang JH; Choi YL
    Histopathology; 2012 Jan; 60(2):347-56. PubMed ID: 22211293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 'Difficult to diagnose' desmoid tumours: a potential role for CTNNB1 mutational analysis.
    Colombo C; Bolshakov S; Hajibashi S; Lopez-Terrada L; Wang WL; Rao P; Benjamin RS; Lazar AJ; Lev D
    Histopathology; 2011 Aug; 59(2):336-40. PubMed ID: 21884214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequent mutations of beta-catenin gene in sporadic secreting adrenocortical adenomas.
    Tadjine M; Lampron A; Ouadi L; Bourdeau I
    Clin Endocrinol (Oxf); 2008 Feb; 68(2):264-70. PubMed ID: 17854394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CTNNB1 Mutations and Estrogen Receptor Expression in Neuromuscular Choristoma and Its Associated Fibromatosis.
    Carter JM; Howe BM; Hawse JR; Giannini C; Spinner RJ; Fritchie KJ
    Am J Surg Pathol; 2016 Oct; 40(10):1368-74. PubMed ID: 27259010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. β-Catenin mutation status and outcomes in sporadic desmoid tumors.
    Mullen JT; DeLaney TF; Rosenberg AE; Le L; Iafrate AJ; Kobayashi W; Szymonifka J; Yeap BY; Chen YL; Harmon DC; Choy E; Yoon SS; Raskin KA; Hornicek FJ; Nielsen GP
    Oncologist; 2013; 18(9):1043-9. PubMed ID: 23960186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta-catenin mutations do not contribute to cardiac fibroma pathogenesis.
    Miller DV; Wang H; Wang H; Fealey ME; Tazelaar HD
    Pediatr Dev Pathol; 2008; 11(4):291-4. PubMed ID: 18078366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathological features of 70 desmoid-type fibromatoses confirmed by β-catenin immunohistochemical staining and CTNNB1 mutation analysis.
    An J; Woo HY; Lee Y; Kim HS; Jeong J; Kim SK
    PLoS One; 2021; 16(4):e0250619. PubMed ID: 33914771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor).
    Tejpar S; Nollet F; Li C; Wunder JS; Michils G; dal Cin P; Van Cutsem E; Bapat B; van Roy F; Cassiman JJ; Alman BA
    Oncogene; 1999 Nov; 18(47):6615-20. PubMed ID: 10597266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors in desmoid-type fibromatosis: a clinicopathological and immunohistochemical analysis of 46 cases.
    Huang PW; Tzen CY
    Pathology; 2010 Feb; 42(2):147-50. PubMed ID: 20085516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequent mutations in the beta-catenin gene in desmoid tumors from patients without familial adenomatous polyposis.
    Miyoshi Y; Iwao K; Nawa G; Yoshikawa H; Ochi T; Nakamura Y
    Oncol Res; 1998; 10(11-12):591-4. PubMed ID: 10367940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tcf-3 expression and beta-catenin mediated transcriptional activation in aggressive fibromatosis (desmoid tumour).
    Tejpar S; Li C; Yu C; Poon R; Denys H; Sciot R; Van Cutsem E; Cassiman JJ; Alman BA
    Br J Cancer; 2001 Jul; 85(1):98-101. PubMed ID: 11437409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations.
    Demunter A; Libbrecht L; Degreef H; De Wolf-Peeters C; van den Oord JJ
    Mod Pathol; 2002 Apr; 15(4):454-61. PubMed ID: 11950921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. beta-Catenin nuclear accumulation in head and neck mucoepidermoid carcinoma: its role in cyclin D1 overexpression and tumor progression.
    Shiratsuchi H; Nakashima T; Hirakawa N; Toh S; Nakagawa T; Saito T; Tsuneyoshi M; Komune S
    Head Neck; 2007 Jun; 29(6):577-84. PubMed ID: 17315172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CTNNB1 S45F mutation predicts poor efficacy of meloxicam treatment for desmoid tumors: a pilot study.
    Hamada S; Futamura N; Ikuta K; Urakawa H; Kozawa E; Ishiguro N; Nishida Y
    PLoS One; 2014; 9(5):e96391. PubMed ID: 24788118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wnt targets genes are not differentially expressed in desmoid tumors bearing different activating β-catenin mutations.
    Timbergen MJM; Janssen ML; Verhoef C; Grünhagen DJ; Chibon F; Smid M; Sleijfer S; Wiemer EAC
    Eur J Surg Oncol; 2019 Apr; 45(4):691-698. PubMed ID: 30528042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic and prognostic impact of beta-catenin alterations in pediatric liver tumors.
    Yamaoka H; Ohtsu K; Sueda T; Yokoyama T; Hiyama E
    Oncol Rep; 2006 Mar; 15(3):551-6. PubMed ID: 16465411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accumulation of beta-catenin protein, mutations in exon-3 of the beta-catenin gene and a loss of heterozygosity of 5q22 in solid pseudopapillary tumor of the pancreas.
    Min Kim S; Sun CD; Park KC; Kim HG; Lee WJ; Choi SH
    J Surg Oncol; 2006 Oct; 94(5):418-25. PubMed ID: 16967453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel pathogenic alterations in pediatric and adult desmoid-type fibromatosis - A systematic analysis of 204 cases.
    Trautmann M; Rehkämper J; Gevensleben H; Becker J; Wardelmann E; Hartmann W; Grünewald I; Huss S
    Sci Rep; 2020 Feb; 10(1):3368. PubMed ID: 32099073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High frequency of beta-catenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease management.
    Dômont J; Salas S; Lacroix L; Brouste V; Saulnier P; Terrier P; Ranchère D; Neuville A; Leroux A; Guillou L; Sciot R; Collin F; Dufresne A; Blay JY; Le Cesne A; Coindre JM; Bonvalot S; Bénard J
    Br J Cancer; 2010 Mar; 102(6):1032-6. PubMed ID: 20197769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinicopathological and molecular genetic features of neuromuscular choristoma-associated desmoid type fibromatosis].
    Dong RF; Guo W; Li N; Wang ZY; Sun XQ; Ding Y
    Zhonghua Bing Li Xue Za Zhi; 2024 Jul; 53(7):685-690. PubMed ID: 38955699
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.